Judith Greer
Obstetrics & Gynecology · Houston, TXNPI 1710149133
Payments from drug & device makers
Across 85 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$318
- Biogen$168
- Exeltis, USA Inc.$144
- Sumitomo Pharma America, Inc.$97
- Mayne Pharma Commercial LLC$89
- Avion Pharmaceuticals$87
- plus $448 from 14 others
What the payments were for
- Food & beverage$1,352100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $318 |
| Biogen | 7 | $168 |
| Exeltis, USA Inc. | 9 | $144 |
| Sumitomo Pharma America, Inc. | 4 | $97 |
| Mayne Pharma Commercial LLC | 7 | $89 |
| Avion Pharmaceuticals | 5 | $87 |
| Axonics, Inc. | 2 | $82 |
| Pfizer | 5 | $61 |
| Shield Therapeutics Inc | 4 | $57 |
| Bayer | 2 | $50 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Optumhealth Care Solutions, LLC | 1 | $24 |
| Organon | 1 | $20 |
| Myovant Sciences Inc. | 1 | $18 |
| Evofem Biosciences, Inc. | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $17 |
| Novo Nordisk | 1 | $15 |
| Millicent US Inc | 1 | $15 |
| Merck | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $11 |
How this compares
$1,352 in reported general payments places this provider in the 55th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 62 | $5,044 |
| ProgesteroneProgesterone, Micronized | 86 | $4,399 |
| Np ThyroidThyroid,pork | 13 | $904 |
| Raloxifene Hcl | 13 | $319 |
| Solifenacin Succinate | 17 | $298 |
| Spironolactone | 25 | $259 |
| Fluconazole | 20 | $116 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $87 |
| Amitriptyline Hcl | 14 | $76 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Houston
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- Mark JacobsHouston$2.8M
- Sandra HurtadoHouston$1.7M
- Dawn BlackHouston$1.2M
- George KuhnHouston$244K
- Luis Sandoval-MartinezHouston$234K
- Daisy AyimHouston$188K
- Asha BhalwalHouston$151K
- Monica LopezFort Worth$8.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.